It took another year for the FDA to grant interchangeability status to Rezvoglar, meaning it can be substituted at the pharmacy for Lantus, the brand name insulin glargine, without needing a ...

It contains the active drug insulin glargine, a long-acting form of insulin. Also called basal or background insulin, these insulin types do not peak like shorter-acting insulins and can help ...

A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...

Tambe said the company, a subsidiary of the Bengaluru-based Biocon Ltd, has five products in the pipeline for launch in the ...

The development follows an announcement in December 2024 when EVA Pharma and Eli Lilly received approval from the Egyptian ...